BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic.MethodsWe surveyed investigators of RCTs which were approved by RECs in 2012 or in 2016 and asked for RCT preparation costs using a pre-specified item list. Additionall...
In spite of advances in the treatment of cardiovascular disease, there remains a significant need fo...
Questions under study: This study represents a first attempt at estimating Swiss resource allocation...
AIMS OF THE STUDY: Premature discontinuation occurs in about 25% of randomised clinical trials in Sw...
BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and ...
The preparation of a randomized controlled trial (RCT) requires substantial resources and the admini...
Objectives Randomised clinical trials (RCTs) are costly. We aimed to provide a systematic overview o...
Objectives Randomised clinical trials (RCTs) are costly and published information on resource requir...
Introduction: We launched an investigator-initiated study (ISRCTN31181395) to evaluate the potential...
Healthcare costs, particularly pharmaceutical costs, are a dominant issue for most healthcare organi...
Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aimed to descri...
Background: Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aim...
BACKGROUND/AIMS Several countries are working to adapt clinical trial regulations to align the ap...
Randomized controlled trials (RCTs) conducted by the industry are expensive, especially trials condu...
Premature discontinuation occurs in about 25% of randomised clinical trials in Switzerland; it mainl...
Well-conducted randomized clinical trials (RCT) areessential for the objective assessment of the val...
In spite of advances in the treatment of cardiovascular disease, there remains a significant need fo...
Questions under study: This study represents a first attempt at estimating Swiss resource allocation...
AIMS OF THE STUDY: Premature discontinuation occurs in about 25% of randomised clinical trials in Sw...
BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and ...
The preparation of a randomized controlled trial (RCT) requires substantial resources and the admini...
Objectives Randomised clinical trials (RCTs) are costly. We aimed to provide a systematic overview o...
Objectives Randomised clinical trials (RCTs) are costly and published information on resource requir...
Introduction: We launched an investigator-initiated study (ISRCTN31181395) to evaluate the potential...
Healthcare costs, particularly pharmaceutical costs, are a dominant issue for most healthcare organi...
Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aimed to descri...
Background: Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aim...
BACKGROUND/AIMS Several countries are working to adapt clinical trial regulations to align the ap...
Randomized controlled trials (RCTs) conducted by the industry are expensive, especially trials condu...
Premature discontinuation occurs in about 25% of randomised clinical trials in Switzerland; it mainl...
Well-conducted randomized clinical trials (RCT) areessential for the objective assessment of the val...
In spite of advances in the treatment of cardiovascular disease, there remains a significant need fo...
Questions under study: This study represents a first attempt at estimating Swiss resource allocation...
AIMS OF THE STUDY: Premature discontinuation occurs in about 25% of randomised clinical trials in Sw...